Clinical trial for Glaucoma
Official title The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston Keratoprosthesis
ClinicalTrials.gov ID: NCT04232982
What this study is testing
- What it's testing
- This study is testing whether a laser treatment before surgery helps control high eye pressure. It compares two different ways of using the laser.
- Who it's for
- You may be able to join if you are scheduled to get a Boston keratoprosthesis (a special plastic eye part).
- What's involved
- You would get a laser treatment to your eye 4 to 8 weeks before your main surgery. You would also have regular eye checks and tests after the surgery.
- Time commitment
- The study lasts for 5 years, with visits every 4 to 6 months after your surgery.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults patients
- Able to give an informed consent
- Capable of being followed during the study
- Candidate for the Boston keratoprosthesis type I
You likely can't join if
- Patients younger than 18 years old or older than 80 years old
- Unable to give an informed consent
- Participating to another treatment glaucoma study
- Patients who received a glaucoma surgery or procedure (glaucoma drainage device or TS-CPC treatment) 3 months before their initial visit.
- Unable to wear a therapeutic contact lens secondary to eyelid malformation
- Severe Ocular surface Disease with keratinization
See the full eligibility criteria
- Adults patients
- Able to give an informed consent
- Capable of being followed during the study
- Candidate for the Boston keratoprosthesis type I
- Patients younger than 18 years old or older than 80 years old
- Unable to give an informed consent
- Participating to another treatment glaucoma study
- Patients who received a glaucoma surgery or procedure (glaucoma drainage device or TS-CPC treatment) 3 months before their initial visit.
- Unable to wear a therapeutic contact lens secondary to eyelid malformation
- Severe Ocular surface Disease with keratinization
- Intra-ocular tumor
- Terminal Glaucoma
- Phthisis bulbi
- Ocular albinism
The study team makes the final eligibility decision.
Where it is enrolling
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Montreal, Quebec, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.